Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
-
Rally House Breaks Company Online Sales Record After Electric Sports Weekend
-
Replicor publishes data from its compassionate access program in HBV/HDV
-
Accent Aesthetics Unveils "Season of Giving & Beauty" Campaign Partnering with Bgoldn to Fight Food Insecurity
-
Louisiana Author Peggy Sweeney-McDonald Releases Life in the A-Zone--A Heartfelt Memoir About Alzheimer's Caregiving, Family Resilience, and Finding "Pink Cloud Moments"
-
Prologis announces redemption of 3.00% Notes due 2026
-
Emergency Restoration Services Available 24/7 in Aurora
-
Expert Construction Services Available in Brooklyn
-
Fortem Cybersecurity, the New Global Cybersecurity Brand from Maguen Group, Officially Launches
-
StickyHive Launches First AI Community Management Software Built Natively for Leading Online Community Platforms
-
/C O R R E C T I O N -- China International Supply Chain Expo/
-
Libya Positions Itself at the Heart of Africa's Gas Future as LAIGF 2025 Kicks Off in Tripoli
-
Celebrate the Holidays at Miami's Premier Strip Club
-
Reborn Pelvic Health & Wellness: Utah's Top Choice for Pelvic Floor Therapy
-
Top Roofing Services Available in Los Lunas, New Mexico
-
Interview Coder 2.0 Launches with Audio AI, Discreet Interview Support, and Lifetime Access Model
-
Leading Construction Services in Bulverde TX
-
Zumba Remodeling Expands Home Improvement Services in Elmont NY
-
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
-
IBC Advanced Alloys Reports Results from its 2025 Annual General Meeting
-
Local Dealer Named Best Used Car Dealer for 2025
-
TulaSoul Announces Empowerment Program to Help Women Reclaim Their Embodiment and Personal Sovereignty
-
Local Dealer Named TIME Dealer of the Year Semifinalist
-
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)
-
Lavnlux Introduces Porto, a Face-Shielding Shower Helmet Designed to Enhance At-Home Wellness
-
The James Agency Announces Strategic Evolution Toward Marketing Consultancy Model
-
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
-
ADAM S. KUTNER, INJURY ATTORNEYS, CELEBRATES FOUR PRESTIGIOUS 2025 BEST OF LAS VEGAS GOLD AWARDS
-
Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Mu
-
Elysium Wealth Advisors Announces Expert Financial Services for Expatriates
-
Azerbaijan has launched it’s first-ever student satellite
-
PEARL HARBOR AVIATION MUSEUM LAUNCHES $51 MILLION "REMEMBER PEARL HARBOR" NATIONAL CAMPAIGN ON DECEMBER 7th TO RESTORE AMERICA'S WORLD WAR II AVIATION BATTLEFIELD
-
New Era Releases 2025 Major League Soccer Champions Collection Celebrating Inter Miami CF
-
The 4th China International Supply Chain Expo Set for Beijing in June 2026
-
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
-
Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
-
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
-
Nayax Considering an Offering of Notes and Warrants in Israel
-
SOUTH32 Hermosa Mine Discharge Shows Antimony Above State Alert Level and Near Regulatory Limit, Raising Concerns About Water Quality Trends
-
Real Estate Expert Kerry Ramage of Melbourne, FL, Breaks Down Home Sale Strategy for HelloNation
-
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
-
CellCentric Presents Positive Phase 2 Dose Optimization Data for Inobrodib in Multiple Myeloma at ASH Annual Meeting
-
Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting
-
Yescarta® Delivers Consistent Safety, Efficacy, and Quality of Life Benefits Across Broad Range of Relapsed/Refractory Large B-cell Lymphoma Patients in New Analysis at ASH 2025
-
Orna Therapeutics Presents New Data Supporting its in vivo CAR Programs for Autoimmune Diseases and Oncology at the 67th American Society of Hematology Annual Meeting
-
Mutuum Finance (MUTM) Approaches 100% Presale Sellout Amid Ongoing Halborn Security Review
-
ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodg
-
Manufacturing Expert James Gizzi of Rochester Discusses How to Choose a CNC Machine Shop in HelloNation
-
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R²) in Patients with Relap
-
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relaps
